Enhanced Angiogenic Potential of Electrically Stimulated Human Adipose-Derived Mesenchymal Stem Cells (MSCs) for Ischemic Tissue Regeneration

Abstract

Effective treatment of ischemic disease requires the reconstruction of blood vessels through the delivery of angiogenic factors, such as chemicals, proteins, and cells. In particular, substantial efforts have focused on enhancing the therapeutic potential of mesenchymal stem cells (MSCs) for treating ischemic diseases. In this study, we investigated the use of electrical stimulation (ES) to potentiate the proangiogenic properties of human adipose-derived MSCs. Electrically potentiated MSCs (epMSCs) were generated by applying optimized ES parameters (0.3 V, 100 Hz). EpMSCs exhibited significantly enhanced angiogenic potential, including upregulated expression of proangiogenic factors (e.g., vascular endothelial growth factor [VEGF]-A and hepatocyte growth factor) and improved endothelial cell migration and tube formation in vitro. Transcriptomic and proteomic analyses revealed activation of key angiogenic pathways, particularly VEGFA–VEGFR2 signaling, which plays a critical role in enhancing the functionality of epMSCs. In vivo studies using a murine hindlimb ischemia model demonstrated that epMSCs enhanced blood flow recovery, induced angiogenesis, and reduced muscle atrophy more effectively than unstimulated MSCs. Overall, these findings suggest that electrical potentiation of MSCs is a promising strategy for effectively enhancing their angiogenic capabilities for treating ischemic diseases.

Keywords

mesenchymal stem cells / electrical stimulation / paracrine effects / angiogenesis / ischemia

References

[1] P. Carmeliet, “Angiogenesis in Life, Disease and Medicine,” Nature 438, no. 7070 (2005): 932-936.

[2] S. W. Cho, F. Yang, S. M. Son, et al., “Therapeutic Angiogenesis Using Genetically Engineered Human Endothelial Cells,” J Control Release 160, no. 3 (2012): 515-524.

[3] E. J. Kim, R. K. Li, R. D. Weisel, et al., “Angiogenesis by Endothelial Cell Transplantation,” The Journal of Thoracic and Cardiovascular Surgery 122, no. 5 (2001): 963-971.

[4] Q. Sun, R. R. Chen, Y. Shen, D. J. Mooney, S. Rajagopalan, and P. M. Grossman, “Sustained Vascular Endothelial Growth Factor Delivery Enhances Angiogenesis and Perfusion in Ischemic Hind Limb,” Pharmaceutical Research 22, no. 7 (2005): 1110-1116.

[5] Z. Li, K. D. Wilson, B. Smith, et al., “Functional and Transcriptional Characterization of human Embryonic Stem Cell-derived Endothelial Cells for Treatment of Myocardial Infarction,” PLoS ONE 4, no. 12 (2009): e8443.

[6] W. Z. Zhuang, Y. H. Lin, L. J. Su, et al., “Mesenchymal Stem/Stromal Cell-based Therapy: Mechanism, Systemic Safety and Biodistribution for Precision Clinical Applications,” Journal of Biomedical Science 28, no. 1 (2021): 28.

[7] M. F. Pittenger, D. E. Discher, B. M. Péault, D. G. Phinney, J. M. Hare, and A. I. Caplan, “Mesenchymal Stem Cell Perspective: Cell Biology to Clinical Progress,” Npj Regen Med 4, no. 1 (2019): 1-15.

[8] S. Maacha, H. Sidahmed, S. Jacob, et al., “Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis,” Stem Cells Int 2020 (2020): 4356359.

[9] H. M. Kwon, S. M. Hur, K. Y. Park, et al., “Multiple Paracrine Factors Secreted by Mesenchymal Stem Cells Contribute to Angiogenesis,” Vascular Pharmacology 63, no. 1 (2014): 19-28.

[10] S. Rautiainen, T. Laaksonen, and R. Koivuniemi, “Angiogenic Effects and Crosstalk of Adipose-Derived Mesenchymal Stem/Stromal Cells and Their Extracellular Vesicles With Endothelial Cells,” International Journal of Molecular Sciences 22, no. 19 (2021): 10890.

[11] W. Fan, D. Sun, and J. Liu, “Adipose Stromal Cells Amplify Angiogenic Signaling via the VEGF/mTOR/Akt Pathway in a Murine Hindlimb Ischemia Model: A 3D Multimodality Imaging Study,” PLoS ONE 7, no. 9 (2012): e45621.

[12] M. Zygmunt, F. Herr, K. Münstedt, U. Lang, and O. D. Liang, “Angiogenesis and Vasculogenesis in Pregnancy,” European Journal of Obstetrics & Gynecology and Reproductive Biology 110 (2003): S10-S18.

[13] S. Li, J. Sun, J. Yang, et al., “Gelatin Methacryloyl (GelMA) Loaded With Concentrated Hypoxic Pretreated Adipose-derived Mesenchymal Stem Cells(ADSCs) Conditioned Medium Promotes Wound Healing and Vascular Regeneration in Aged Skin,” Biomaterials Research 27, no. 1 (2023): 11.

[14] L. Liu, J. Gao, Y. Yuan, Q. Chang, Y. Liao, and F. Lu, “Hypoxia Preconditioned human Adipose Derived Mesenchymal Stem Cells Enhance Angiogenic Potential via Secretion of Increased VEGF and bFGF,” Cell Biology International 37, no. 6 (2013): 551-560.

[15] C. Liu, Y. Fan, L. zhou, et al., “Pretreatment of Mesenchymal Stem Cells With Angiotensin II Enhances Paracrine Effects, Angiogenesis, Gap Junction Formation and Therapeutic Efficacy for Myocardial Infarction,” International Journal of Cardiology 188 (2015): 22-32.

[16] H. Z. Zhang, S. Han, and S. W. Kim, “SDF-1-edited human Amniotic Mesenchymal Stem Cells Stimulate Angiogenesis in Treating Hindlimb Ischaemia,” Journal of Cellular and Molecular Medicine 26, no. 13 (2022): 3726-3735.

[17] C. N. de Noronha, A. Mizukami, C. Caliári-Oliveira, et al., “Priming Approaches to Improve the Efficacy of Mesenchymal Stromal Cell-based Therapies,” Stem Cell Research & Therapy 10, no. 1 (2019): 131.

[18] X. Wan, Z. Liu, and L. Li, “Manipulation of Stem Cells Fates: The Master and Multifaceted Roles of Biophysical Cues of Biomaterials,” Advanced Functional Materials 31, no. 23 (2021): 2010626.

[19] J. Li, Y. Liu, Y. Zhang, et al., “Biophysical and Biochemical Cues of Biomaterials Guide Mesenchymal Stem Cell Behaviors,” Frontiers in Cell and Developmental Biology 9 (2021): 640388. Accessed August 28, 2023.

[20] M. R. Love, S. Palee, S. C. Chattipakorn, and N. Chattipakorn, “Effects of Electrical Stimulation on Cell Proliferation and Apoptosis,” Journal of Cellular Physiology 233, no. 3 (2018): 1860-1876.

[21] M. Guillot-Ferriols, S. Lanceros-Méndez, J. L. Gómez Ribelles, and G. Gallego Ferrer, “Electrical Stimulation: Effective Cue to Direct Osteogenic Differentiation of Mesenchymal Stem Cells?,” Biomaterials Advances 138 (2022): 212918.

[22] J. G. Hardy, R. C. Sukhavasi, and D. Aguilar, “Electrical Stimulation of human Mesenchymal Stem Cells on Biomineralized Conducting Polymers Enhances Their Differentiation towards Osteogenic Outcomes,” Journal of Materials Chemistry B 3, no. 41 (2015): 8059-8064.

[23] J. G. Hardy, M. K. Villancio-Wolter, R. C. Sukhavasi, et al., “Electrical Stimulation of Human Mesenchymal Stem Cells on Conductive Nanofibers Enhances Their Differentiation Toward Osteogenic Outcomes,” Macromolecular Rapid Communications 36, no. 21 (2015): 1884-1890.

[24] M. Eischen-Loges, K. M. C. Oliveira, M. B. Bhavsar, J. H. Barker, and L. Leppik, “Pretreating Mesenchymal Stem Cells With Electrical Stimulation Causes Sustained Long-lasting Pro-osteogenic Effects,” PeerJ 6 (2018): e4959.

[25] J. Beugels, D. G. M. Molin, D. Ophelders, et al., “Electrical Stimulation Promotes the Angiogenic Potential of Adipose-derived Stem Cells,” Scientific Reports 9, no. 1 (2019): 12076.

[26] N. Tandon, B. Goh, A. Marsano, et al., “Alignment and Elongation of human Adipose-derived Stem Cells in Response to Direct-current Electrical Stimulation,” Annu Int Conf IEEE Eng Med Biol Soc 2009 (2009): 6517-6521.

[27] J. Yi, Y. Byun, S. S. Kang, K. M. Shim, K. Jang, and J. Y. Lee, “Enhanced Chondrogenic Differentiation of Electrically Primed Human Mesenchymal Stem Cells for the Regeneration of Osteochondral Defects,” Biomaterials Research 28 (2024): 0109.

[28] T. Kaga, H. Kawano, M. Sakaguchi, T. Nakazawa, Y. Taniyama, and R. Morishita, “Hepatocyte Growth Factor Stimulated Angiogenesis Without Inflammation: Differential Actions Between Hepatocyte Growth Factor, Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor,” Vascular Pharmacology 57, no. 1 (2012): 3-9.

[29] C. Chang, J. Yan, Z. Yao, C. Zhang, X. Li, and H. Mao, “Effects of Mesenchymal Stem Cell-Derived Paracrine Signals and Their Delivery Strategies,” Adv Healthc Mater 10, no. 7 (2021): 2001689.

[30] Z. Xie, J. Chen, C. Wang, J. Zhang, Y. Wu, and X. Yan, “Current Knowledge of Krüppel-Like Factor 5 and Vascular Remodeling: Providing Insights for Therapeutic Strategies,” Journal of Molecular Cell Biology 13, no. 2 (2021): 79-90.

[31] J. L. Arbiser, J. Petros, R. Klafter, et al., “Reactive Oxygen Generated by Nox1 Triggers the Angiogenic Switch,” PNAS 99, no. 2 (2002): 715-720.

[32] V. Duval, P. Alayrac, J. S. Silvestre, and A. Levoye, “Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases,” Front Endocrinol (Lausanne) 13 (2022): 906586.

[33] A. T. Ehrlich, M. Semache, P. Couvineau, et al., “Ackr3-Venus Knock-in Mouse Lights up Brain Vasculature,” Molecular Brain 14, no. 1 (2021): 151.

[34] Y. Chen, A. B. Rabson, and D. H. Gorski, “MEOX2 regulates Nuclear Factor-κB Activity in Vascular Endothelial Cells Through Interactions With p65 and IκBβ,” Cardiovascular Research 87, no. 4 (2010): 723-731.

[35] K. Ohashi, T. Enomoto, Y. Joki, et al., “Neuron-derived Neurotrophic Factor Functions as a Novel Modulator That Enhances Endothelial Cell Function and Revascularization Processes,” Journal of Biological Chemistry 289, no. 20 (2014): 14132-14144.

[36] Z. Zhou, C. Lu, S. Meng, et al., “Silencing of PTGS2 Exerts Promoting Effects on Angiogenesis Endothelial Progenitor Cells in Mice With Ischemic Stroke via Repression of the NF-κB Signaling Pathway,” Journal of Cellular Physiology 234, no. 12 (2019): 23448-23460.

[37] M. Song and S. D. Finley, “ERK and Akt Exhibit Distinct Signaling Responses Following Stimulation by Pro-angiogenic Factors,” Cell Communication and Signaling 18, no. 1 (2020): 114.

[38] B. Zhang, T. M. A. Adesanya, L. Zhang, et al., “Delivery of Placenta-derived Mesenchymal Stem Cells Ameliorates Ischemia Induced Limb Injury by Immunomodulation,” Cellular Physiology and Biochemistry 34, no. 6 (2014): 1998-2006.

[39] G. A. Meyer, “Evidence of Induced Muscle Regeneration Persists for Years in the Mouse,” Muscle & Nerve 58, no. 6 (2018): 858-862.

[40] L. Wang, T. G. Valencak, and T. Shan, “Fat Infiltration in Skeletal Muscle: Influential Triggers and Regulatory Mechanism,” Iscience 27, no. 3 (2024): 109221.

[41] C. Chen, X. Bai, Y. Ding, and I. S. Lee, “Electrical Stimulation as a Novel Tool for Regulating Cell Behavior in Tissue Engineering,” Biomater Res 23 (2019): 25.

[42] C. Chen, X. Bai, Y. Ding, and I. S. Lee, “Electrical Stimulation as a Novel Tool for Regulating Cell Behavior in Tissue Engineering,” Biomaterials Research 23, no. 1 (2019): 25.

[43] R. Srinivasan, T. Zabuawala, H. Huang, et al., “Erk1 and Erk2 Regulate Endothelial Cell Proliferation and Migration During Mouse Embryonic Angiogenesis,” PLoS ONE 4, no. 12 (2009): e8283.

[44] E. Glaab, A. Baudot, N. Krasnogor, R. Schneider, and A. Valencia, “EnrichNet: Network-based Gene Set Enrichment Analysis,” Bioinformatics 28, no. 18 (2012): i451-i457.

[45] H. Jo, M. Sim, S. Kim, et al., “Electrically Conductive Graphene/Polyacrylamide Hydrogels Produced by Mild Chemical Reduction for Enhanced Myoblast Growth and Differentiation,” Acta Biomaterialia 48 (2017): 100-109.

[46] H. Y. Gong, J. Park, W. Kim, J. Kim, J. Y. Lee, and W. G. Koh, “A Novel Conductive and Micropatterned PEG-Based Hydrogel Enabling the Topographical and Electrical Stimulation of Myoblasts,” ACS Appl Mater Interfaces 11, no. 51 (2019): 47695-47706.

[47] S. Kim, L. K. Jang, M. Jang, S. Lee, J. G. Hardy, and J. Y. Lee, “Electrically Conductive Polydopamine-Polypyrrole as High Performance Biomaterials for Cell Stimulation in Vitro and Electrical Signal Recording in Vivo,” ACS Appl Mater Interfaces 10, no. 39 (2018): 33032-33042.

[48] C. T. Liu, J. Yu, M. H. Lin, et al., “Biophysical Electrical and Mechanical Stimulations for Promoting Chondrogenesis of Stem Cells on PEDOT:PSS Conductive Polymer Scaffolds,” Biomacromolecules 24, no. 8 (2023): 3858-3871.

[49] K. J. Livak, and T. D. Schmittgen, “Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method,” Methods (San Diego, Calif.) 25, no. 4 (2001): 402-408.

[50] B. Liu, Y. Kong, W. Shi, et al., “Exosomes Derived From Differentiated human ADMSC With the Schwann Cell Phenotype Modulate Peripheral Nerve-related Cellular Functions,” Bioactive Materials 14 (2022): 61-75.

[51] A. Shevchenko, H. Tomas, J. Havli, J. V. Olsen, and M. Mann, “In-gel Digestion for Mass Spectrometric Characterization of Proteins and Proteomes,” Nature Protocols 1, no. 6 (2006): 2856-2860.

[52] J. Park, G. Choe, S. Oh, and J. Y. Lee, “In Situ Formation of Proangiogenic Mesenchymal Stem Cell Spheroids in Hyaluronic Acid/Alginate Core-Shell Microcapsules,” ACS Biomater Sci Eng 6, no. 12 (2020): 6938-6948.

[53] S. Lee, G. Choe, J. Yi, et al., “ROS-scavenging Ultrasonicated Graphene Oxide/Alginate Microgels for Mesenchymal Stem Cell Delivery and Hindlimb Ischemia Treatment,” Materials Today Bio 29 (2024): 101289.

[54] Y. Perez-Riverol, C. Bandla, D. J. Kundu, et al., “The PRIDE Database at 20 Years: 2025 Update,” Nucleic Acids Res. 53, no. D1 (2024): D543-D553.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.